284 related articles for article (PubMed ID: 33878706)
1. SalvGlandDx - a comprehensive salivary gland neoplasm specific next generation sequencing panel to facilitate diagnosis and identify therapeutic targets.
Freiberger SN; Brada M; Fritz C; Höller S; Vogetseder A; Horcic M; Bihl M; Michal M; Lanzer M; Wartenberg M; Borner U; Bode PK; Broglie MA; Rordorf T; Morand GB; Rupp NJ
Neoplasia; 2021 May; 23(5):473-487. PubMed ID: 33878706
[TBL] [Abstract][Full Text] [Related]
2. The Role of Molecular Testing in the Differential Diagnosis of Salivary Gland Carcinomas.
Skálová A; Stenman G; Simpson RHW; Hellquist H; Slouka D; Svoboda T; Bishop JA; Hunt JL; Nibu KI; Rinaldo A; Vander Poorten V; Devaney KO; Steiner P; Ferlito A
Am J Surg Pathol; 2018 Feb; 42(2):e11-e27. PubMed ID: 29076877
[TBL] [Abstract][Full Text] [Related]
3. Microsecretory Adenocarcinoma: A Novel Salivary Gland Tumor Characterized by a Recurrent MEF2C-SS18 Fusion.
Bishop JA; Weinreb I; Swanson D; Westra WH; Qureshi HS; Sciubba J; MacMillan C; Rooper LM; Dickson BC
Am J Surg Pathol; 2019 Aug; 43(8):1023-1032. PubMed ID: 31094920
[TBL] [Abstract][Full Text] [Related]
4. The PRKD1 E710D hotspot mutation is highly specific in separating polymorphous adenocarcinoma of the palate from adenoid cystic carcinoma and pleomorphic adenoma on FNA.
Andreasen S; Melchior LC; Kiss K; Bishop JA; Høgdall E; Grauslund M; Wessel I; Homøe P; Agander TK
Cancer Cytopathol; 2018 Apr; 126(4):275-281. PubMed ID: 29266837
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Molecular Characterization of Polymorphous Adenocarcinoma, Cribriform Subtype: Identifying Novel Fusions and Fusion Partners.
Hahn E; Xu B; Katabi N; Dogan S; Smith SM; Perez-Ordonez B; Patel PB; MacMillan C; Lubin DJ; Gagan J; Weinreb I; Bishop JA
Mod Pathol; 2023 Nov; 36(11):100305. PubMed ID: 37595638
[TBL] [Abstract][Full Text] [Related]
6. SS18 Break-Apart Fluorescence In Situ Hybridization is a Practical and Effective Method for Diagnosing Microsecretory Adenocarcinoma of Salivary Glands.
Bishop JA; Koduru P; Veremis BM; Oliai BR; Weinreb I; Rooper LM; Dickson BC; Demicco EG
Head Neck Pathol; 2021 Sep; 15(3):723-726. PubMed ID: 33394377
[TBL] [Abstract][Full Text] [Related]
7. Molecular Profiling of Salivary Gland Intraductal Carcinoma Revealed a Subset of Tumors Harboring NCOA4-RET and Novel TRIM27-RET Fusions: A Report of 17 cases.
Skálová A; Vanecek T; Uro-Coste E; Bishop JA; Weinreb I; Thompson LDR; de Sanctis S; Schiavo-Lena M; Laco J; Badoual C; Santana Conceiçao T; Ptáková N; Baněčkova M; Miesbauerová M; Michal M
Am J Surg Pathol; 2018 Nov; 42(11):1445-1455. PubMed ID: 30045065
[TBL] [Abstract][Full Text] [Related]
8. Detection of salivary gland and sinonasal fusions by a next-generation sequencing based, ligation-dependent, multiplex RT-PCR assay.
Lanic MD; Guérin R; Wassef M; Durdilly P; Rainville V; Sater V; Jardin F; Ruminy P; Costes-Martineau V; Laé M
Histopathology; 2023 Nov; 83(5):685-699. PubMed ID: 37350081
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of 1p36 locus deletion in adenoid cystic carcinoma of the salivary glands.
Šteiner P; Andreasen S; Grossmann P; Hauer L; Vaněček T; Miesbauerová M; Santana T; Kiss K; Slouka D; Skálová A
Virchows Arch; 2018 Oct; 473(4):471-480. PubMed ID: 29619555
[TBL] [Abstract][Full Text] [Related]
10. Using pan-TRK and RET Immunohistochemistry for the Detection of Fusion Types of Salivary Gland Secretory Carcinoma.
Su YJ; Lee YH; Jin YT; Hsieh MS
Appl Immunohistochem Mol Morphol; 2022 Apr; 30(4):264-272. PubMed ID: 35384876
[TBL] [Abstract][Full Text] [Related]
11. Targeted RNA sequencing in the routine clinical detection of fusion genes in salivary gland tumors.
Bubola J; MacMillan CM; Demicco EG; Chami RA; Chung CT; Leong I; Marrano P; Onkal Z; Swanson D; Veremis BM; Weinreb I; Zhang L; Antonescu CR; Dickson BC
Genes Chromosomes Cancer; 2021 Oct; 60(10):695-708. PubMed ID: 34176176
[TBL] [Abstract][Full Text] [Related]
12. Salivary gland polymorphous adenocarcinoma: Clinicopathological features and gene alterations in 36 Japanese patients.
Fukumura M; Ishibashi K; Nakaguro M; Nagao T; Saida K; Urano M; Tanigawa M; Hirai H; Yagyuu T; Kikuchi K; Yada N; Sugita Y; Miyabe M; Hasegawa S; Goto M; Yamamoto H; Ohuchi T; Kusafuka K; Ogawa I; Suzuki H; Notohara K; Shimoda M; Tada Y; Kirita T; Takata T; Morinaga S; Maeda H; Warnakulasuriya S; Miyabe S; Nagao T
J Oral Pathol Med; 2022 Sep; 51(8):710-720. PubMed ID: 35880805
[TBL] [Abstract][Full Text] [Related]
13. The evolving role of molecular pathology in the diagnosis of salivary gland tumours with potential pitfalls.
Kaur K; Mehta S; Vanik S; Trivedi P; Banerjee N; Dhar H; Datta S; Karanjai S
Eur Arch Otorhinolaryngol; 2022 Aug; 279(8):3769-3783. PubMed ID: 35267084
[TBL] [Abstract][Full Text] [Related]
14. Novel PRKD gene rearrangements and variant fusions in cribriform adenocarcinoma of salivary gland origin.
Weinreb I; Zhang L; Tirunagari LM; Sung YS; Chen CL; Perez-Ordonez B; Clarke BA; Skalova A; Chiosea SI; Seethala RR; Waggott D; Boutros PC; How C; Liu FF; Irish JC; Goldstein DP; Gilbert R; Ud Din N; Assaad A; Hornick JL; Thompson LD; Antonescu CR
Genes Chromosomes Cancer; 2014 Oct; 53(10):845-56. PubMed ID: 24942367
[TBL] [Abstract][Full Text] [Related]
15. Microsecretory adenocarcinoma of the skin harboring recurrent SS18 fusions: A cutaneous analog to a newly described salivary gland tumor.
Bishop JA; Williams EA; McLean AC; Gagan J; Rooper LM; Jordan RCK; LeBoit PE
J Cutan Pathol; 2023 Feb; 50(2):134-139. PubMed ID: 35690998
[TBL] [Abstract][Full Text] [Related]
16. Reevaluation of MAML2 fusion-negative mucoepidermoid carcinoma: a subgroup being actually hyalinizing clear cell carcinoma of the salivary gland with EWSR1 translocation.
Hsieh MS; Wang H; Lee YH; Ko JY; Chang YL
Hum Pathol; 2017 Mar; 61():9-18. PubMed ID: 27769871
[TBL] [Abstract][Full Text] [Related]
17. Histologic spectrum of polymorphous adenocarcinoma of the salivary gland harbor genetic alterations affecting PRKD genes.
Sebastiao APM; Xu B; Lozada JR; Pareja F; Geyer FC; Da Cruz Paula A; da Silva EM; Ghossein RA; Weinreb I; de Noronha L; Weigelt B; Reis-Filho JS; Katabi N
Mod Pathol; 2020 Jan; 33(1):65-73. PubMed ID: 31492931
[TBL] [Abstract][Full Text] [Related]
18. Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations.
Mitani Y; Liu B; Rao PH; Borra VJ; Zafereo M; Weber RS; Kies M; Lozano G; Futreal PA; Caulin C; El-Naggar AK
Clin Cancer Res; 2016 Feb; 22(3):725-33. PubMed ID: 26631609
[TBL] [Abstract][Full Text] [Related]
19. Molecular Profiling of Salivary Oncocytic Mucoepidermoid Carcinomas Helps to Resolve Differential Diagnostic Dilemma With Low-grade Oncocytic Lesions.
Skálová A; Agaimy A; Stanowska O; Baneckova M; Ptáková N; Ardighieri L; Nicolai P; Lombardi D; Durzynska M; Corcione L; Laco J; Koshyk O; Žalud R; Michal M; Vanecek T; Leivo I
Am J Surg Pathol; 2020 Dec; 44(12):1612-1622. PubMed ID: 33002921
[TBL] [Abstract][Full Text] [Related]
20. Adenoid Cystic Carcinoma With Striking Tubular Hypereosinophilia: A Unique Pattern Associated With Nonparotid Location and Both Canonical and Novel EWSR1::MYB and FUS::MYB Fusions.
Weinreb I; Rooper LM; Dickson BC; Hahn E; Perez-Ordonez B; Smith SM; Lewis JS; Skalova A; Baněčková M; Wakely PE; Thompson LDR; Rupp NJ; Freiberger SN; Koduru P; Gagan J; Bishop JA
Am J Surg Pathol; 2023 Apr; 47(4):497-503. PubMed ID: 36920022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
